Nabriva Therapeutics PLC (FRA:NTY)
€ 0.665 0.065 (10.83%) Market Cap: 1.90 Mil Enterprise Value: 753,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Q1 2022 Nabriva Therapeutics PLC Earnings Call Transcript

May 05, 2022 / 08:30PM GMT
Release Date Price: €7.05 (+2.92%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Nabriva Therapeutics First Quarter 2022 Earnings Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the call over to Dan Dolan, Nabriva's Chief Financial Officer. You may begin.

Daniel Dolan
Nabriva Therapeutics plc - CFO

Thank you, Gretchen, and good afternoon, everyone. Welcome to Nabriva's conference call and webcast where we will be discussing the first quarter 2022 earnings and providing a business update. The slides for today's presentation are posted on the company's website, www.nabriva.com, and can be found under the Investors tab in the Events & Presentations section. We recommend that you refer to the presentation, as we will be using those slides for today's discussion.

Before we begin, on Slide 2, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot